London South East Logo | UK Share Price information



Register
Login:
Share:
Email Facebook Twitter




Clinigen Share Price (CLIN)



Share Price Information for Clinigen (CLIN)


Share Price: 1,049.50Bid: 1,049.00Ask: 1,050.00Change: -0.50 (-0.05%)Faller - Clinigen
Spread: 1.00Spread as %: 0.10%Open: 1,057.00High: 1,057.50Low: 1,045.00Yesterday’s Close: 1,050.00

Clinigen Group Plc Ord 0.1P

Clinigen is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Clinigen is part of the Household Utilities sector






Share Price SpacerPrice
1049.50

Share Price SpacerBid
1049.00

Share Price SpacerAsk
1050.00

Share Price SpacerChange
-0.05%-0.50

Share Price SpacerVolume
113,528

Share Price SpacerOpen
1,057.00

Share Price SpacerHigh
1,057.50

Share Price SpacerLow
1,045.00

Share Price SpacerClose
1,050.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 122.29m £1,283.39m 2,000

52 Week High 1,187.00 52 Week High Date 1-NOV-2017
52 Week Low 753.00 52 Week Low Date 23-MAR-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
175 10,649 102,251 318.030 3.30 4.30 0.41


London South East Users info for Clinigen




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

19-Jan-18
09:24:32
1,050.00
99
Buy* 
1,049.00
1,050.00
1,040
Trade Type:
Automatic execution

19-Jan-18
09:23:52
1,050.00
59
Buy* 
1,049.00
1,050.00
619.50
Trade Type:
Automatic execution

19-Jan-18
09:23:52
1,050.00
108
Buy* 
1,049.00
1,050.00
1,134
Trade Type:
Automatic execution




View more Clinigen trades >>

Directors Deals for Clinigen (CLIN)
Trade DateActionNotifierPriceCurrencyAmountHolding
23-Nov-17Sell
Trade Notifier Information for Clinigen Group
Chris Rigg held the position of Executive Director at Clinigen Group at the time of this trade.
 Chris Rigg
1017GBX4,9551608
13-Oct-17Sell
Trade Notifier Information for Clinigen Group
Shaun Edward Chilton held the position of Managing Director and CEO at Clinigen Group at the time of this trade.
 Shaun Edward Chilton
1150GBX100,000312943
02-Oct-17Sell
Trade Notifier Information for Clinigen Group
John Bacon held the position of Non-Executive Director at Clinigen Group at the time of this trade.
 John Bacon
1092.96GBX250,000280767
View more Clinigen directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Wed 14:40robinsTrading Update1,001.25No Opinion
Forgot about the Link deferred consideration payment too. That probably explains things.
Wed 08:59robinsTrading Update1,019.00No Opinion
Part of the increase in debt will be due to the QP and IMMC acquisitions but not all of it. Again bit disappointed.
Wed 08:28robinsTrading Update1,026.50No Opinion
With revenues up 28% I am a bit disappointed with the gross profit up just by 10%. Suppose the increase in debt is purely due to the QP acquisition. Looks like I will be holding here a bit longer.
Tue 16:34robinsDip1,032.00No Opinion
took a dip at the end. Just hope tomorrows update is positive.
11 Jan '18finnharps1thought1,041.00No Opinion
we would pull away from 1040 today havnt opened around 1049...........may still do it before close......hopefully. Still fairly confident we will hit £11+ before or after trading update next Wed.
9 Jan '18finnharps1Improvement1,027.00No Opinion
But still struggling to break 1040......17th Jan for trading update. Still think we will hit £11+.....hopefully.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Clinigen (CLIN) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.